scholarly article | Q13442814 |
P50 | author | Laurent P Nicod | Q37368680 |
Sejal Saglani | Q42608323 | ||
Clare M. Lloyd | Q56992813 | ||
Rebekah Sherburn | Q63378242 | ||
Koshika Yadava | Q63378250 | ||
Benjamin J Marsland | Q87606067 | ||
Aurélien Trompette | Q93162634 | ||
Eva S. Gollwitzer | Q105916547 | ||
P2093 | author name string | Kathy D McCoy | |
P2860 | cites work | Analysis of the lung microbiome in the "healthy" smoker and in COPD | Q21091065 |
Disordered microbial communities in asthmatic airways | Q21562589 | ||
Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 | ||
Interactions between the microbiota and the immune system | Q27028155 | ||
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota | Q29614272 | ||
Interactions between commensal intestinal bacteria and the immune system | Q29617039 | ||
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells | Q30080038 | ||
Intestinal microbial diversity during early-life colonization shapes long-term IgE levels | Q33725722 | ||
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 | ||
The development of the immune system during pregnancy and early life | Q34012447 | ||
The development of inducible bronchus-associated lymphoid tissue depends on IL-17. | Q34191942 | ||
The lung microbiome in moderate and severe chronic obstructive pulmonary disease | Q34448176 | ||
The airway microbiome and disease | Q34897317 | ||
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
Effects of viral respiratory infections on lung development and childhood asthma | Q36086948 | ||
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells | Q36742588 | ||
Living on a farm: impact on asthma induction and clinical course | Q37197717 | ||
Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? | Q37493607 | ||
The role of rhinovirus infections in the development of early childhood asthma | Q37649333 | ||
Evidence for a causal relationship between respiratory syncytial virus infection and asthma | Q37929751 | ||
Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis | Q37995031 | ||
Farm-derived Gram-positive bacterium Staphylococcus sciuri W620 prevents asthma phenotype in HDM- and OVA-exposed mice | Q39201577 | ||
Use of antibiotics during pregnancy increases the risk of asthma in early childhood | Q42287087 | ||
Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise | Q43521483 | ||
Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism | Q44435591 | ||
Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. | Q45157679 | ||
Farm living: effects on childhood asthma and allergy | Q57197946 | ||
Foetal exposure to maternal passive smoking is associated with childhood asthma, allergic rhinitis, and eczema | Q57631571 | ||
Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses | Q60556933 | ||
Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation | Q81617509 | ||
Dysregulation of allergic airway inflammation in the absence of microbial colonization | Q83797978 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 642-647 | |
P577 | publication date | 2014-05-11 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Lung microbiota promotes tolerance to allergens in neonates via PD-L1 | |
P478 | volume | 20 |
Q26795697 | A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models |
Q35847339 | A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes |
Q87782754 | A curious connection: Teasing apart the link between gut microbes and lung disease |
Q41570635 | A novel approach for predicting microbe-disease associations by bi-random walk on the heterogeneous network. |
Q64913678 | Active Tonic mTORC1 Signals Shape Baseline Translation in Naive T Cells. |
Q35898526 | Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period |
Q46787507 | Aging and the microbiome: implications for asthma in the elderly? |
Q33752095 | Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants. |
Q38890722 | Airway Microbiota and the Implications of Dysbiosis in Asthma |
Q37715936 | Alterations of the murine gut microbiome in allergic airway disease are independent of surfactant protein D |
Q93174461 | Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs |
Q40189399 | An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease. |
Q39992669 | An analysis of human microbe-disease associations |
Q48155143 | Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases. |
Q56956806 | Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy |
Q28365058 | Asthma and the microbiome: defining the critical window in early life |
Q33707521 | Bacteria isolated from lung modulate asthma susceptibility in mice |
Q41622001 | Batf3 deficiency is not critical for the generation of CD8α⁺ dendritic cells |
Q37677661 | Beyond Hygiene: Commensal Microbiota and Allergic Diseases |
Q28067227 | Breathing Better Through Bugs: Asthma and the Microbiome |
Q37276771 | CD301b+ dendritic cells suppress T follicular helper cells and antibody responses to protein antigens |
Q41758607 | Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology |
Q36323325 | Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin |
Q39228603 | Correlation between early-life regulation of the immune system by microbiota and allergy development |
Q55092065 | Correlation of Severity of Functional Gastrointestinal Disease Symptoms with that of Asthma and Chronic Obstructive Pulmonary Disease: A Multicenter Study. |
Q38925678 | Current status of the microbiome in renal transplantation |
Q64075553 | Cytokines and Chemokines as Biomarkers of Future Asthma |
Q26743564 | Dendritic cells in lung immunopathology |
Q28831420 | Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery |
Q47773664 | Development of a Stable Lung Microbiome in Healthy Neonatal Mice |
Q39402872 | Development of allergic immunity in early life. |
Q26768646 | Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma? |
Q36302757 | Dynamic changes of the respiratory microbiota and its relationship to fecal and blood microbiota in healthy young cats |
Q91651052 | Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety |
Q47607410 | Early Origins of Asthma: Role of Microbial Dysbiosis and Metabolic Dysfunction |
Q38683893 | Early life factors that affect allergy development |
Q91404964 | Early life home microbiome and hyperactivity/inattention in school-age children |
Q39135685 | Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. |
Q91868549 | Environment and Host-Genetic Determinants in Early Development of Allergic Asthma: Contribution of Fungi |
Q97643941 | Excess calorie intake early in life increases susceptibility to colitis in adulthood |
Q52589510 | Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development. |
Q39094699 | Extracellular Vesicles, a Key Mediator to Link Environmental Microbiota to Airway Immunity |
Q38947692 | First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment |
Q48108006 | GAPs in early life facilitate immune tolerance. |
Q89805617 | Group 2 Innate Lymphoid Cells: Central Players in a Recurring Theme of Repair and Regeneration |
Q38573631 | Group 2 innate lymphoid cells in disease |
Q93049115 | Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response |
Q40731595 | Gut microbiota and protection from pneumococcal pneumonia |
Q55428575 | Gut microbiota components are associated with fixed airway obstruction in asthmatic patients living in the tropics. |
Q41614058 | Has the airway microbiome been overlooked in respiratory disease? |
Q35612185 | Helsinki alert of biodiversity and health |
Q27300777 | High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers |
Q39296277 | Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma |
Q107473554 | Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs |
Q35955467 | Host-microbiome interactions in acute and chronic respiratory infections |
Q95840390 | Host-microbiota interactions in immune-mediated diseases |
Q46810894 | Host-microorganism interactions in lung diseases |
Q28069301 | How colonization by microbiota in early life shapes the immune system |
Q35105292 | Imbalance of dendritic cell co-stimulation in COPD. |
Q87898913 | Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis |
Q92979252 | Imprinting of the immune system by the microbiota early in life |
Q39363751 | Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota |
Q47555954 | Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. |
Q47120261 | Innate Immunity to Respiratory Infection in Early Life. |
Q95320368 | Interaction between microbiota and immunity in health and disease |
Q90320710 | LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma |
Q38973369 | Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients |
Q36135913 | Linking microbiota and respiratory disease |
Q90706587 | Lower Airway Microbiota |
Q35043299 | Lunasin alleviates allergic airway inflammation while increases antigen-specific Tregs |
Q91893359 | Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer |
Q38739840 | Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. |
Q35736479 | Lungs, microbes and the developing neonate |
Q39309033 | Maturation of the Infant Respiratory Microbiota, Environmental Drivers and Health Consequences: A Prospective Cohort Study |
Q34502460 | Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome |
Q93042013 | Microbes, metabolites, and the gut-lung axis |
Q46257092 | Microbial Insights into Asthmatic Immunopathology. A Forward-Looking Synthesis and Commentary. |
Q94545387 | Microbiome Composition and Its Impact on the Development of Allergic Diseases |
Q26798677 | Microbiome and Asthma: What Have Experimental Models Already Taught Us? |
Q47228960 | Microbiome and asthma |
Q35230090 | Microbiome diversity and asthma and allergy risk |
Q55424073 | Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation. |
Q33754038 | Microbiota in T-cell homeostasis and inflammatory diseases |
Q35631743 | Microbiota in allergy and asthma and the emerging relationship with the gut microbiome |
Q41048687 | Microbiota, regulatory T cell subsets, and allergic disorders |
Q35627459 | Microbiota—implications for immunity and transplantation |
Q89533644 | Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies |
Q52338712 | Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin. |
Q35921692 | Mucosal immunoglobulins at respiratory surfaces mark an ancient association that predates the emergence of tetrapods |
Q39474002 | Murine models for mucosal tolerance in allergy |
Q55293109 | Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma. |
Q34801150 | Neonatal hyperoxia leads to persistent alterations in NK responses to influenza A virus infection |
Q34540798 | Neonatal mucosal immunology |
Q26830616 | New developments providing mechanistic insight into the impact of the microbiota on allergic disease |
Q55409227 | Novel human microbe-disease associations inference based on network consistency projection. |
Q90468731 | Novel vaccines targeting dendritic cells by coupling allergoids to mannan |
Q89761262 | Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle |
Q35926923 | Obesity, Asthma, and the Microbiome |
Q59807082 | Occurrence and Dynamism of Lactic Acid Bacteria in Distinct Ecological Niches: A Multifaceted Functional Health Perspective |
Q64257569 | Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics |
Q58729114 | Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma |
Q48613713 | Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B. |
Q47561020 | Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion |
Q47704287 | Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes |
Q94464342 | Predicting Microbe-Disease Association by Learning Graph Representations and Rule-Based Inference on the Heterogeneous Network |
Q38720306 | Prioritizing disease-causing microbes based on random walking on the heterogeneous network |
Q57279756 | Probiotics as a Potential Immunomodulating Pharmabiotics in Allergic Diseases: Current Status and Future Prospects |
Q37839059 | Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease |
Q50000630 | Progress in the understanding of the pathology of allergic asthma and the potential of fruit proanthocyanidins as modulators of airway inflammation. |
Q40594698 | Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation |
Q98735557 | Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury |
Q47108657 | Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity? |
Q91142624 | Pulmonary group 2 innate lymphoid cells: surprises and challenges |
Q38702812 | Respiratory microbiota and lower respiratory tract disease. |
Q41987385 | Role of microbiota on lung homeostasis and diseases. |
Q38662859 | Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease |
Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
Q93109740 | T cell anergy in perinatal mice is promoted by T reg cells and prevented by IL-33 |
Q91822570 | T cells in severe childhood asthma |
Q64090843 | The ABCs of wheeze: Asthma and bacterial communities |
Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
Q90094635 | The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks |
Q41159836 | The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces |
Q89727343 | The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy |
Q35828936 | The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. |
Q38853672 | The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease |
Q39077395 | The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis. |
Q47638694 | The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma. |
Q89787316 | The Role of Lung and Gut Microbiota in the Pathology of Asthma |
Q50420279 | The Role of the Microbiome in the Developmental Origins of Health and Disease. |
Q41673062 | The Value of a Comparative Approach to Understand the Complex Interplay between Microbiota and Host Immunity |
Q35721479 | The airway microbiome in patients with severe asthma: Associations with disease features and severity. |
Q35594963 | The changing face of asthma and its relation with microbes |
Q37547143 | The developing hypopharyngeal microbiota in early life |
Q33820414 | The development of lower respiratory tract microbiome in mice |
Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
Q58790648 | The hygiene hypothesis: immunological mechanisms of airway tolerance |
Q39329232 | The immune response to Prevotella bacteria in chronic inflammatory disease. |
Q41996494 | The immunology of the allergy epidemic and the hygiene hypothesis |
Q36481368 | The innate immune function of airway epithelial cells in inflammatory lung disease |
Q35496335 | The interplay between the intestinal microbiota and the immune system |
Q64450801 | The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation |
Q38750982 | The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology |
Q38949256 | The microbiome in asthma |
Q28080434 | The microbiome in asthma |
Q39001907 | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases |
Q58724159 | The microbiota in the intestinal and respiratory tracts of naked mole-rats revealed by high-throughput sequencing |
Q34553608 | The microbiota of the respiratory tract: gatekeeper to respiratory health |
Q38547303 | The need to differentiate between adults and children when treating severe asthma |
Q49786774 | The neonatal window of opportunity-early priming for life. |
Q28275178 | The possible mechanisms of the human microbiome in allergic diseases |
Q39444008 | The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. |
Q35430866 | The respiratory microbiome and innate immunity in asthma |
Q38599199 | The respiratory tract microbial biogeography in alcohol use disorder |
Q38331964 | The rural-urban enigma of allergy: what can we learn from studies around the world? |
Q35755585 | The transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system |
Q33880637 | Three distinct pneumotypes characterize the microbiome of the lung in BALB/cJ mice |
Q55284399 | Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells. |
Q91045962 | Translation control of the immune checkpoint in cancer and its therapeutic targeting |
Q39382368 | Unique aspects of the perinatal immune system |
Q98503965 | Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment |
Q37272779 | Vitamin D and allergic airway disease shape the murine lung microbiome in a sex-specific manner |
Q27024394 | Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology |
Q100560002 | γδ T cells in tissue physiology and surveillance |
Search more.